Insights from the FAST-TRACK CABG Experience in Complex Multivessel Disease

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational, prospective, multicenter European study analyzing patients from the FAST-TRACK CABG trial. It uses patient-reported outcome measures (Seattle Angina Questionnaire) and clinical outcomes (MACCE, NYHA class, cardiovascular hospitalization, and death) to explore prognostic value of imaging markers. Data include Lipoprotein(a) levels and pre-CABG CCTA imaging with FFRCT-guided revascularization. The aim is to determine if preoperative imaging biomarkers correlate with post-CABG symptom improvement and major adverse events. Enrollment requires informed consent and analyzable pre-CABG imaging.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients who have analyzable pre-CABG CCTA imaging and received a successful CCTA-guided plus FFRCT CABG procedure.
* Patient with known level of Lp(a) or with possibility to perform the test
* Patent able to provide written informed consent as approved by the Ethical Committee

Exclusion Criteria:

* Patients without pre-CABG CCTA imaging or those with who did not receive surgical revascularization.
* Current treatment with lipoprotein apheresis
* Patients who refuse to receive clinical follow-up
* Unable to give Informed Consent

Where it's running

• Centro Cardiologico Monzino; IRCCS
  Milan, Mi, Italy Recruiting

Study contacts

• Study coordinator: Gianluca Pontone, MD
• Email: gianluca.pontone@cardiologicomonzino.it
• Phone: 0258002574

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Inspiron EVO stent in complex coronary lesions in Brazil

  This study tests how well and safely the Inspiron EVO drug-eluting stent works in real-world patients with complex coronary artery disease in Brazil.

  Recruiting Scitech Produtos Medicos SA · Porto Alegre, Rio Grande do Sul · NCT07491107

• Bypass surgery versus stents for people with weak heart pumping and blockages in multiple coronary arteries

  This trial tests whether bypass surgery (CABG) or stents (PCI) lead to better survival, fewer major heart problems, and improved quality of life for adults with reduced left ventricular function (LVEF ≤40%) and multivessel coronary disease.

  Recruiting University Medical Center Groningen · Groningen · NCT07269366

• Temporary heart support with the iVAC 2L device during high-risk coronary procedures

  This trial will try the iVAC 2L temporary heart‑support device during high‑risk PCI to help people with severe coronary artery disease stay hemodynamically stable through the procedure.

  Recruiting National Medical Research Center for Cardiology, Ministry of Health of Russian Federation · Moscow · NCT07149714

• Cardiac MRI to find tissue damage and predict outcomes after coronary revascularization

  This study will test whether heart MRI scans can help predict which adults with reduced heart pumping function and multivessel coronary disease are more likely to have heart failure, readmission, or death after planned stent or bypass procedures.

  Recruiting at 10 sites Weill Medical College of Cornell University · Brooklyn, New York and 9 other locations · NCT07133984

• Investigating the effects of balloon occlusion on angina in patients with multi-vessel coronary artery disease

  This study is testing how different blockages in the heart's arteries affect chest pain in people with multiple artery problems.

  Recruiting at 7 sites Imperial College London · Basildon and 7 other locations · NCT06400290

• Comparing complete revascularization to culprit lesion only PCI in NSTEMI patients

  This study tests if treating all blocked arteries instead of just the main problem artery helps people with NSTEMI feel better and recover faster.

  Recruiting at 39 sites Leipzig Heart Science gGmbH · Graz and 57 other locations · NCT05786131

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.